EPB0189 | Reversibility of neuropsychiatric adverse events after switching to Darunavir/cobicistat or Doravirine in men on INSTI based regimen | E-poster | Clinical complications of HIV and antiretroviral therapy |
EPC0337 | Retrospective cohort study of factors associated with non-initiation of antiretroviral therapy among adults newly diagnosed with HIV in Andijan, Uzbekistan, 2018-2021 | E-poster | Surveillance: Measuring the HIV epidemic |
EPE0805 | Rethinking DREAMS completion: comparison of approaches in the Zimbabwean context | E-poster | Implementation science and scale up of prevention |
EPE0767 | Retesting for HIV among individuals on ART during community-based distribution of HIV self-tests – a mixed-methods study in rural Zimbabwe | E-poster | Implementation science and scale up of HIV testing |
LBEPC29 | Retention and clinical outcomes improve after implementation of test and treat policy among children living with HIV in Zambia: a retrospective cohort study | E-poster | Cascades of HIV care and treatment |
EPE0796 | Results of the end-line evaluation of a PrEP demonstration project among MSM and TGW in Myanmar | E-poster | Implementation science and scale up of prevention |
TUPEB18 | Resistance to second generation integrase inhibitors after two years of a national rollout strategy in Mexico | Poster exhibition | ART resistance |
OAA0102 | Resident microbiota enhance HIV acquisition, replication, and pathogenesis in vivo | Oral abstract session with live Q&A | HIV pathogenesis |
TUPEE11 | Reproductive coercion, viral suppression, and integrated sexual and reproductive health services among women living with HIV in 11 countries | Poster exhibition | HIV and development synergies |
OAD0102 | Reporting, prevention and response of gender based violence against men who have sex with men in Taraba State, Nigeria | Oral abstract session with live Q&A | Social and behavioural aspects and approaches to HIV |